Business
Isomorphic Labs raises $5B, its third round in 20 months. It still hasn't dosed a human — what to watch
The Google DeepMind drug-discovery spinout closed a $5 billion Series C co-led by Greenoaks and Sequoia, taking outside funding to roughly $7.7 billion. It won't disclose a valuation, and the real test is whether its first AI-designed drug enters clinical trials by the end-of-2026 target Demis Hassabis set in January.